1. Home
  2. NTHI vs IRBT Comparison

NTHI vs IRBT Comparison

Compare NTHI & IRBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • IRBT
  • Stock Information
  • Founded
  • NTHI 2008
  • IRBT 1990
  • Country
  • NTHI United States
  • IRBT United States
  • Employees
  • NTHI N/A
  • IRBT N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • IRBT Consumer Electronics/Appliances
  • Sector
  • NTHI Health Care
  • IRBT Consumer Discretionary
  • Exchange
  • NTHI Nasdaq
  • IRBT Nasdaq
  • Market Cap
  • NTHI 110.9M
  • IRBT 130.0M
  • IPO Year
  • NTHI N/A
  • IRBT N/A
  • Fundamental
  • Price
  • NTHI $5.10
  • IRBT $4.88
  • Analyst Decision
  • NTHI
  • IRBT Hold
  • Analyst Count
  • NTHI 0
  • IRBT 1
  • Target Price
  • NTHI N/A
  • IRBT N/A
  • AVG Volume (30 Days)
  • NTHI 284.4K
  • IRBT 2.9M
  • Earning Date
  • NTHI 01-01-0001
  • IRBT 08-05-2025
  • Dividend Yield
  • NTHI N/A
  • IRBT N/A
  • EPS Growth
  • NTHI N/A
  • IRBT N/A
  • EPS
  • NTHI N/A
  • IRBT N/A
  • Revenue
  • NTHI $79,990.00
  • IRBT $633,404,000.00
  • Revenue This Year
  • NTHI N/A
  • IRBT $3.23
  • Revenue Next Year
  • NTHI N/A
  • IRBT $28.90
  • P/E Ratio
  • NTHI N/A
  • IRBT N/A
  • Revenue Growth
  • NTHI 13.52
  • IRBT N/A
  • 52 Week Low
  • NTHI $3.20
  • IRBT $1.76
  • 52 Week High
  • NTHI $25.00
  • IRBT $13.45
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • IRBT 61.53
  • Support Level
  • NTHI N/A
  • IRBT $4.28
  • Resistance Level
  • NTHI N/A
  • IRBT $5.52
  • Average True Range (ATR)
  • NTHI 0.00
  • IRBT 0.54
  • MACD
  • NTHI 0.00
  • IRBT 0.07
  • Stochastic Oscillator
  • NTHI 0.00
  • IRBT 65.78

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").

About IRBT iRobot Corporation

iRobot Corp is a United state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried out both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online stores. The company derives its revenue from the product sales. It sells the products across the United States and around the world.

Share on Social Networks: